Global $9.3 Bn Radiotherapy Market 2017-2024 - Mergers and Acquisitions to Expand Business

News provided by

Research and Markets

Oct 20, 2017, 16:00 ET

DUBLIN, October 20, 2017 /PRNewswire/ --

The "Global Radiotherapy Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

In this report, global radiotherapy market is projected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024.

Scope of the Report

  • The global radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy.
  • Radiotherapy market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy.
  • The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology.
  • The brachytherapy is segmented into LDR and HDR.
  • On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy software and systematic radiotherapy.
  • External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife.
  • The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders.
  • The radiotherapy software is segmented into treatment planning softwares, dosage planning softwares, patient positioning software and image guiding softwares.
  • On the basis of indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.

Market Overview

Drivers

  • Growing Prevalence of Cancer
  • Rising Ageing Population
  • Unhealthy Lifestyle
  • Mergers and Acquisitions to Expand Business

Restraints

  • Regulatory Scenario
  • High Cost of Radiotherapy

Opportunities

  • Growing Medical Tourism in Asia
  • Emerging Market

Challenges

  • Side-Effects of Radiotherapy
  • Requirement of Trained Staff


Global radiotherapy market competition by top players including:

Varian Medical Systems, Inc. dominated the radiotherapy market followed by Elekta AB, and Accuray, Inc. along with others

  • CIVCO Medical Solutions
  • Brainlab AG
  • C. R. Bard, Inc.
  • IsoRay Medical, Inc.
  • Nordion, Inc.
  • RaySearch Laboratories AB
  • PRECISIS AG
  • Mevion Medical Systems, Inc.
  • TechnicasRadiofiscas S.L.
  • Hitachi, Ltd.
  • Sumitomo Heavy Industries, Ltd.
  • Mitsubishi Electric Corporation
  • ProNova Solutions, LLC
  • ProTom International

Key Topics Covered:

1. Introduction
1.1. Overview of Global Radiotherapy Market
1.1.1. Currency and Pricing
1.1.2. Limitation
1.1.3. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered for the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews with Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Growing Prevalence of Cancer
3.1.2. Rising Ageing Population
3.1.3. Unhealthy Lifestyle
3.1.4. Mergers and Acquisitions to Expand Business
3.2. Restraints
3.2.1. Regulatory Scenario
3.2.2. High Cost of Radiotherapy
3.3. Opportunities
3.3.1. Growing Medical Tourism in Asia
3.3.2. Emerging Market
3.4. Challenges
3.4.1. Side-Effects of Radiotherapy
3.4.2. Requirement of Trained Staff

4. Executive Summary

5. Premium Insights

6. Global Radiotherapy Market, by Therapy Type
6.1. Overview
6.2. Beam Radiotherapy, by Therapy Type
6.3. Brachytherapy, by Therapy Type

7. Global Radiotherapy Market, by Product Type
7.1. Overview
7.2. Global External Beam Radiotherapy Market, by Product Type
7.3. Global Internal Beam Radiotherapy Market, by Product Type
7.4. Global Radiotherapy Software Market, by Product Type

8. Global Radiotherapy Market, by Indication
8.1. Overview

9. Global Radiotherapy Market, by Geography
9.1. Overview
9.2. North America Radiotherapy Market Snapshot: 2016
9.2.1. U.S. Radiotherapy Market
9.2.2. Canada Radiotherapy Market
9.2.3. Mexico Radiotherapy Market
9.3. Europe Radiotherapy Market
9.3.1. Germany Radiotherapy Market
9.3.2. France Radiotherapy Market
9.3.3. U.K. Radiotherapy Market
9.3.4. Switzerland Radiotherapy Market
9.3.5. Italy Radiotherapy Market
9.3.6. Russia Radiotherapy Market
9.3.7. Netherlands Radiotherapy Market
9.3.8. Spain Radiotherapy Market
9.3.9. Belgium Radiotherapy Market
9.3.10. Turkey Radiotherapy Market
9.4. APAC Radiotherapy Market Snapshot: 2016
9.4.1. Japan Radiotherapy Market
9.4.2. China Radiotherapy Market
9.4.3. India Radiotherapy Market
9.4.4. South Korea Radiotherapy Market
9.4.5. Australia Radiotherapy Market
9.4.6. Thailand Radiotherapy Market
9.4.7. Malaysia Radiotherapy Market
9.4.8. Indonesia Radiotherapy Market
9.4.9. Singapore Radiotherapy Market
9.4.10. Philippines Radiotherapy Market
9.5. South America Radiotherapy Market Snapshot: 2016
9.5.1. Brazil Radiotherapy Market
9.6. MEA Radiotherapy Market Snapshot: 2016
9.6.1. Saudi Arabia Radiotherapy Market

10. Global Radiotherapy Market, Company Share
10.1. Company Share Analysis: Global
10.2. Company Share Analysis: North America
10.3. Company Share Analysis: Europe
10.4. Company Share Analysis: Asia Pacific

11. Company Profiles
11.1. Varian Medical Systems, Inc.
11.1.1. Company Overview
11.1.2. SWOT (Strength, Weakness, Opportunities and Threats)
11.1.3. Drivers Explained
11.1.3.1. Diverse Product Portfolio:
11.1.3.2. Strong Research and Development Capabilities:
11.1.4. Weaknesses Explained
11.1.4.1. Dependence on Limited Number of Suppliers:
11.1.5. Opportunities Explained
11.1.5.1. Varian Could Expand Its Position with Imaging Components Business' Spin-Off:
11.1.5.2. Acquisitions Likely to Enhance Varian's Oncology and Imaging Businesses:
11.1.5.3. Expansion in Operations in the U.S.:
11.1.5.4. Increasing Incidence of Cancer to Drive Global Radiation Therapy Equipment Market:
11.1.6. Threats Explained
11.1.6.1. Intense Competition Could Affect Varian'S Market Share and Results of Operation:
11.1.6.2. Increasing Medical Costs in Cancer Treatment and Care: 259
11.1.7. Revenue Analysis
11.1.8. Product Portfolio
11.1.9. Recent Developments
11.1.10. Analysis
11.2. Elekta Ab
11.2.1. Company Overview
11.2.2. Revenue Analysis
11.2.3. Product Portfolio
11.2.4. Recent Developments
11.2.5. Analysis
11.3. Nanobiotix
11.3.1. Company Overview
11.3.2. Revenue Analysis
11.3.3. Product Portfolio
11.3.4. Recent Developments
11.3.5. Analysis
11.4. Accuray, Inc.
11.4.1. Company Overview
11.4.2. Revenue Analysis
11.4.3. Product Portfolio
11.4.4. Recent Developments
11.5. Brainlab Ag
11.5.1. Company Overview
11.5.2. SWOT (Strength, Weakness, Opportunities and Threats)
11.5.3. Drivers Explained
11.5.3.1. Strong Partner Network:
11.5.3.2. Established Presence in Markets:
11.5.4. Weaknesses Explained
11.5.4.1. Product Safety Concerns:
11.5.5. Opportunities Explained
11.5.5.1. Strategic Initiatives:
11.5.6. Threats Explained
11.5.6.1. Rapid Technological Changes:
11.5.6.2. Stringent Government Regulations:
11.5.7. Revenue Analysis
11.5.8. Product Portfolio
11.5.9. Recent Developments
11.6. Ion Beam Applications Sa
11.6.1. Company Overview
11.6.2. Revenue Analysis
11.6.3. Product Portfolio
11.6.4. Recent Developments
11.7. Mevion Medical Systems, Inc.
11.7.1. Company Overview
11.7.2. Revenue Analysis
11.7.3. Product Portfolio
11.7.4. Recent Developments
11.8. Isoray Medical, Inc.
11.8.1. Company Overview
11.8.2. Revenue Analysis
11.8.3. Product Portfolio
11.8.4. Recent Developments
11.9. Nordion (Canada) Inc.
11.9.1. Company Overview
11.9.2. SWOT (Strength, Weakness, Opportunities and Threats)
11.9.3. Drivers Explained
11.9.3.1. Established Presence in Gamma Irradiation Industry:
11.9.4. Weaknesses Explained
11.9.4.1. Radiation Exposure Claims and Other Disputes:
11.9.5. Opportunities Explained
11.9.5.1. Strategic Initiatives:
11.9.6. Threats Explained
11.9.6.1. Rapid Technological Changes:
11.9.6.2. Stringent Government Regulations:
11.9.6.3. Stiff Competition:
11.9.7. Revenue Analysis
11.9.8. Product Portfolio
11.9.9. Recent Developments
11.10. Raysearch Laboratories Ab
11.10.1. Company Overview
11.10.2. Revenue Analysis
11.10.3. Product Portfolio
11.10.4. Recent Developments
11.11. Precisis Ag
11.11.1. Company Overview
11.11.2. Revenue Analysis
11.11.3. Product Portfolio
11.11.4. Recent Developments

12. Related Reports



Companies Mentioned

  • Accuray, Inc.
  • Brainlab AG
  • C. R. Bard, Inc.
  • CIVCO Medical Solutions
  • Elekta AB,
  • Hitachi, Ltd.
  • IsoRay Medical, Inc.
  • Mevion Medical Systems, Inc.
  • Mitsubishi Electric Corporation
  • Nordion, Inc.
  • PRECISIS AG
  • ProNova Solutions, LLC
  • ProTom International
  • RaySearch Laboratories AB
  • Sumitomo Heavy Industries, Ltd.
  • TechnicasRadiofiscas S.L.
  • Varian Medical Systems, Inc.



For more information about this report visit https://www.researchandmarkets.com/research/7v5vdg/global

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

21%

more press release views with 
Request a Demo